Bharat Biotech is likely to conduct clinical trials for an intranasal Covid-19 vaccine candidate, called BBV154, next week. The COVID-19 vaccine-making firm will conduct trials in Patna, Chennai, Hyderabad, and Nagpur. According to the Central Trail Registry of India (CTRI), these trials will be conducted on 175 participants. The Hyderabad-based firm has started the...
- 6 hrs ago